In an industry obsessed with billion-dollar valuations and flashy IPOs, Biotillion is playing a different game entirely. With just 7 employees and a $1.1M revenue, this biotech player is proving that deep vertical focus beats broad horizontal ambition.

"Biotillion isn't chasing scale—they're chasing precision. In biotech, sometimes smaller is smarter."

The traffic split tells a story of trust. When 35% of visitors type your URL directly, you've earned a spot in their workflow. This isn't a discovery play—it's a destination. Biotillion has embedded itself into the daily operations of biotech teams who need reliable sample tracking.

• Vertical dominance in cold chain logistics
• High-value, low-volume customer strategy
• Infrastructure over innovation—proven tech stack
• Direct traffic signals deep customer relationships